(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Golden Globes is happening Sunday: Who's nominated, who's hosting and how to watch - 2Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs
- 3'The Boys' Season 5 premiere: How to watch for less, what to know about the final series and more
- 4Brilliant and Gleaming: Excellence and Skincare Practices
- 5Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- Accomplishing Balance between fun and serious activities: Procedures for a Better Life
- Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
- Germany's far-right AfD tops poll ahead of Merz's conservatives
- Brazil's Bolsonaro to continue his sentence at home because of poor health
- Astronomers spot white dwarf star creating a colorful shockwave
- Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
- Why the UAE has incurred the wrath of Somalia
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- IDF destroys Hamas shaft in northern Gaza with loaded 'ready to fire' rocket aimed at Sderot
